Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Small study tests blood sugar targets before exercise in type 1 diabetes

NCT ID NCT05821322

First seen Mar 16, 2026 · Last updated Jun 22, 2026 · Updated 19 times

Summary

This small, terminated trial aimed to find the best blood glucose target to set 60 minutes before moderate aerobic exercise in adults with type 1 diabetes who use do-it-yourself automated insulin delivery (DIY-AID) systems. Researchers planned to test three different glucose targets (8.3, 8.8, and 9.3 mmol/L) in 32 participants, but only 6 enrolled before the study was stopped. The goal was to see which target leads to the smallest drop in blood sugar during exercise and helps prevent hypoglycemia.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Institut de recherches cliniques de Montréal

    Montreal, Quebec, H2W1R7, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

aerobic exercise (ergocycle) at 60% VO2 peak

What this could lead to

If successful, this could help people with type 1 diabetes using DIY automated insulin delivery systems choose the best blood glucose target before exercise to reduce hypoglycemia risk.

What could go wrong

The trial was terminated early with only 6 participants, so results are very limited and may not apply to others. It was a small, early-stage study testing different glucose targets, not a treatment.

Conditions

The condition(s) this trial relates to.

hypoglycemia type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.